Henric Bjorn Bjarke - 30 Sep 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, COO
Signature
/s/ Henric Bjarke
Issuer symbol
INZY
Transactions as of
30 Sep 2022
Net transactions value
+$7,558
Form type
4
Filing time
04 Oct 2022, 08:00:09 UTC
Previous filing
20 Apr 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $7,558 +3,315 +4.1% $2.28 83,941 30 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2022 through September 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on September 30, 2022.